A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides is a research paper published in eLife (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: R01AI120670
National Institute of Allergy and Infectious Diseases
Grant: R01AI090810
Office of Research Infrastructure Programs
Grant: 1S10OD030263
Fulbright U.S. Student Program
Grant: Pakistan
National Institutes of Health
Grant: 1S10OD030263-01
Vectra Polaris microscope imaging system
National Institutes of Health
Grant: 5R01AI090810-08
Development of Novel Proteins Synthesis Inhibitors for MDR Tuberculosis
National Institutes of Health
Grant: 5R01AI120670-04
Aerosol spectinamide-1599 therapy against tuberculosis
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals